| Crucial role of CB2 cannabinoid receptor in the regulation of central immune responses during neuropathic pain I Racz, X Nadal, J Alferink, JE Banos, J Rehnelt, M Martín, B Pintado, ... Journal of Neuroscience 28 (46), 12125-12135, 2008 | 237 | 2008 |
| Pharmacological properties of S1RA, a new sigma‐1 receptor antagonist that inhibits neuropathic pain and activity‐induced spinal sensitization L Romero, D Zamanillo, X Nadal, R Sánchez‐Arroyos, I Rivera‐Arconada, ... British journal of pharmacology 166 (8), 2289-2306, 2012 | 209 | 2012 |
| Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury B de la Puente, X Nadal, E Portillo-Salido, R Sánchez-Arroyos, S Ovalle, ... Pain 145 (3), 294-303, 2009 | 204 | 2009 |
| Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors E Martínez-Pinilla, K Varani, I Reyes-Resina, E Angelats, F Vincenzi, ... Frontiers in pharmacology 8, 290777, 2017 | 183 | 2017 |
| Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia C Gaveriaux-Ruff, C Nozaki, X Nadal, XC Hever, R Weibel, A Matifas, ... Pain 152 (6), 1238-1248, 2011 | 173 | 2011 |
| Interferon-γ is a critical modulator of CB2 cannabinoid receptor signaling during neuropathic pain I Racz, X Nadal, J Alferink, JE Banos, J Rehnelt, M Martín, B Pintado, ... Journal of Neuroscience 28 (46), 12136-12145, 2008 | 154 | 2008 |
| Neuropathic pain is enhanced in δ‐opioid receptor knockout mice X Nadal, JE Baños, BL Kieffer, R Maldonado European Journal of Neuroscience 23 (3), 830-834, 2006 | 143 | 2006 |
| Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1–CB2 heteroreceptor complexes G Navarro, K Varani, I Reyes-Resina, V Sánchez de Medina, ... Frontiers in pharmacology 9, 366412, 2018 | 130 | 2018 |
| Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity X Nadal, C Del Río, S Casano, B Palomares, C Ferreiro‐Vera, ... British journal of pharmacology 174 (23), 4263-4276, 2017 | 117 | 2017 |
| Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity A Brenchat, X Nadal, L Romero, S Ovalle, A Muro, R Sánchez-Arroyos, ... Pain 149 (3), 483-494, 2010 | 109 | 2010 |
| Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes G Navarro, I Reyes-Resina, R Rivas-Santisteban, VS de Medina, ... Biochemical pharmacology 157, 148-158, 2018 | 90 | 2018 |
| Involvement of the opioid and cannabinoid systems in pain control: new insights from knockout studies X Nadal, C La Porta, SA Bura, R Maldonado European journal of pharmacology 716 (1-3), 142-157, 2013 | 82 | 2013 |
| Pharmacological data of cannabidiol-and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors G Navarro, K Varani, A Lillo, F Vincenzi, R Rivas-Santisteban, I Raïch, ... Pharmacological research 159, 104940, 2020 | 72 | 2020 |
| A2A adenosine receptor regulates glia proliferation and pain after peripheral nerve injury AS Bura, X Nadal, C Ledent, R Maldonado, O Valverde Pain 140 (1), 95-103, 2008 | 71 | 2008 |
| Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity B Palomares, F Ruiz-Pino, M Garrido-Rodriguez, ME Prados, ... Biochemical pharmacology 171, 113693, 2020 | 50 | 2020 |
| Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids R Franco, R Rivas-Santisteban, I Reyes-Resina, M Casanovas, ... Pharmacological research 158, 104801, 2020 | 37 | 2020 |
| A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT 1A Receptors C Echeverry, G Prunell, C Narbondo, VS de Medina, X Nadal, ... Neurotoxicity Research 39, 335-348, 2021 | 35 | 2021 |
| Long‐lasting oral analgesic effects of N‐protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain E Bonnard, H Poras, X Nadal, R Maldonado, MC Fournié‐Zaluski, ... Pharmacology Research & Perspectives 3 (2), e00116, 2015 | 35 | 2015 |
| Methods of purifying cannabinoids, compositions and kits thereof XN Roura US Patent 9,765,000, 2017 | 34 | 2017 |
| Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors I Raïch, R Rivas-Santisteban, A Lillo, J Lillo, I Reyes-Resina, X Nadal, ... Pharmacological Research 174, 105970, 2021 | 17 | 2021 |
